Astria Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	0	0	0	0	0	0	0.5	0	0	0	Upgrade
Gross Profit	0	0	0	0	0	0	0.5	0	0	0	Upgrade
Selling, General & Admin	25.7	19.24	14.81	11.85	8.77	9.33	8.91	10.11	8.63	6	Upgrade
Research & Development	42.13	34.26	15.55	25.59	18.32	17.04	18.68	25.45	23.03	15.69	Upgrade
Other Operating Expenses	15.2	0	164.62	0	0	0	0	0	0	0	Upgrade
Operating Expenses	83.03	53.5	194.98	37.44	27.09	26.37	27.59	35.56	31.66	21.68	Upgrade
Operating Income	-83.03	-53.5	-194.98	-37.44	-27.09	-26.37	-27.09	-35.56	-31.66	-21.68	Upgrade
Interest Expense / Income	0	0	0	0	0	0.1	0.46	0.84	0.98	0.21	Upgrade
Other Expense / Income	-10.14	-1.67	-0.06	-0.14	-0.8	-0.6	-0.19	-0.34	-0.01	-0	Upgrade
Pretax Income	-72.89	-51.83	-194.91	-37.3	-26.29	-25.87	-27.36	-36.06	-32.63	-21.88	Upgrade
Net Income	-72.89	-51.83	-194.91	-37.3	-26.29	-25.87	-27.36	-36.06	-32.63	-21.88	Upgrade
Preferred Dividends	0	0	24.44	0	0	0	0	0	0	0	Upgrade
Net Income Common	-72.89	-51.83	-219.35	-37.3	-26.29	-25.87	-27.36	-36.06	-32.63	-21.88	Upgrade
Shares Outstanding (Basic)	30	15	9	3	2	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	30	15	9	3	2	1	0	0	0	0	Upgrade
Shares Change	106.03%	63.81%	191.81%	63.87%	121.55%	133.14%	33.59%	101.82%	1794.46%	12.00%	Upgrade
EPS (Basic)	-2.42	-3.55	-24.58	-12.20	-14.10	-30.72	-75.72	-133.20	-243.60	-3093.59	Upgrade
EPS (Diluted)	-2.42	-3.55	-24.58	-12.20	-14.10	-30.72	-75.72	-133.20	-243.60	-3093.59	Upgrade
Free Cash Flow	-68.47	-43.62	-30.17	-32.52	-26.58	-23.1	-26.86	-33.27	-30.21	-20.64	Upgrade
Free Cash Flow Per Share	-2.27	-2.98	-3.38	-10.63	-14.24	-27.41	-74.34	-122.97	-225.42	-2917.47	Upgrade
Gross Margin	-	-	-	-	-	-	100.00%	-	-	-	Upgrade
Operating Margin	-	-	-	-	-	-	-5418.80%	-	-	-	Upgrade
Profit Margin	-	-	-	-	-	-	-5472.80%	-	-	-	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-5372.60%	-	-	-	Upgrade
EBITDA	-72.89	-51.83	-194.91	-37.3	-26.29	-25.65	-26.6	-34.83	-31.45	-21.43	Upgrade
EBITDA Margin	-	-	-	-	-	-	-5319.60%	-	-	-	Upgrade
Depreciation & Amortization	0	0	0	0	0	0.12	0.3	0.4	0.2	0.25	Upgrade
EBIT	-72.89	-51.83	-194.91	-37.3	-26.29	-25.77	-26.9	-35.22	-31.65	-21.68	Upgrade
EBIT Margin	-	-	-	-	-	-	-5380.40%	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).